Bethesda, Md—A committee of the Institute of Medicine (IOM) has developed a useful crystal ball for policymakers who have to decide priorities for developing new vaccines, given the available resources. As a way of thinking about different types of vaccines, both preventive and therapeutic, the group estimated the costs and benefits of developing 26 vaccines for managing diseases of domestic importance that were deemed feasible to develop during the next 20 years.
Marwick C. IOM Committee Gazes Into New Vaccine Future. JAMA. 1999;281(15):1366-1367. doi:10.1001/jama.281.15.1366-JMN0421-3-1